Forward this page

Thank you for your interest in spreading the word on FierceVaccines.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
MUC1 cancer vaccine starts in the clinic
(Your Name) has sent you a message from FierceVaccines
(Your Name) thought you would like to see the FierceVaccines web site.

Press Releases

  • Watson Confirms Glumetza® Patent Challenge
  • Positive Currency Effects Help Global Pharmaceutical Market Grow by 5.3 Percent in 2011, Although Lower Growth Expected Going Forward Due to Cost Containment and Key Patent Expiries
  • PROLOR Biotech Announces Positive Results of Its Obesity/Diabetes Drug Candidate in Preclinical Weight Loss Study
  • Possible new cancer treatment identified
  • Cell Therapeutics Enters into Agreement to Acquire Pacritinib, a Novel Highly Selective JAK2 Inhibitor Phase 3 Candidate for Myelofibrosis

Featured Jobs